Pitango HealthTech Fund I L.P. 13D and 13G filings for TScan Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 06:02 am Purchase | 2023-12-31 | 13G | TScan Therapeutics, Inc. TCRX | Pitango HealthTech Fund I L.P. | 2,079,985 4.300% | 1,000,000 (+92.59%) | Filing |
| 2022-02-14 09:38 am Purchase | 2021-12-31 | 13G | TScan Therapeutics, Inc. TCRX | Pitango HealthTech Fund I L.P. | 1,079,985 4.600% | 1,079,985 (New Position) | Filing |